Members access detailed protocols, evidence-based monitoring guides, and a community of researchers navigating every aspect of GLP-1 therapy with precision and care
For oral semaglutide, the PIONEER 6 trial showed non-inferiority for cardiovascular safety, though it is important to note that Rybelsus does not have a specific licensed indication for cardiovascular risk reduction in the UK
Method for preparing in vivo formulation: Take PEG300, mix and clarify, next add 2 Omix and clarify
The Journal of clinical endocrinology and metabolism , 103 (6), 22912301
Stopping treatment prematurely can lead to serious neurological complications
GLP-1 is also produced in the brain, particularly from preproglucagon neurons, which are distributed in the solitary tract of the brain stem, and it functions as a neuropeptide [2,3,4,5]